Cargando…

Ophthalmic artery occlusion after glabellar hyaluronic acid filler injection

PURPOSE: Filler injections for aesthetic purposes are very popular, but can have far-reaching and irreversible consequences. This report describes the course of a patient with devastating complications after glabellar hyaluronic acid injection, their pathomechanism, management and outcome. OBSERVATI...

Descripción completa

Detalles Bibliográficos
Autores principales: Davidova, Petra, Müller, Michael, Wenner, Yaroslava, König, Clara, Kenikstul, Ninel, Kohnen, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858863/
https://www.ncbi.nlm.nih.gov/pubmed/35243152
http://dx.doi.org/10.1016/j.ajoc.2022.101407
_version_ 1784654326561505280
author Davidova, Petra
Müller, Michael
Wenner, Yaroslava
König, Clara
Kenikstul, Ninel
Kohnen, Thomas
author_facet Davidova, Petra
Müller, Michael
Wenner, Yaroslava
König, Clara
Kenikstul, Ninel
Kohnen, Thomas
author_sort Davidova, Petra
collection PubMed
description PURPOSE: Filler injections for aesthetic purposes are very popular, but can have far-reaching and irreversible consequences. This report describes the course of a patient with devastating complications after glabellar hyaluronic acid injection, their pathomechanism, management and outcome. OBSERVATIONS: A healthy, 43-year-old woman underwent her first hyaluronic acid injection in the glabella and went blind on her left eye immediately thereafter. Massaging of the injection area and observation were performed, before she presented with swelling of the left forehead and upper lid, ptosis, complete ophthalmoplegia and blindness in our hospital. Immediate massaging of the globe and systemic therapy including acetylsalicylic acid, tinzaparin sodium and cortisone was initiated and hyaluronidase injections in the injection area were performed. In the further course, the patient developed necrotic and hemorrhagic skin and mucosal lesions, lagophthalmos, anterior and posterior segment ischemia and globe hypotonia with consecutive globe deformation. In the follow-up of 2.5 months, lid swelling, lagophthalmos and ptosis resolved and keratopathy improved but blindness, skin lesions and strabismus with reduced eye motility were still present and madarosis and early enophthalmos were detected. CONCLUSIONS AND IMPORTANCE: The outcome of ophthalmic artery occlusion after hyaluronic acid filler injection is poor. Sufficient knowledge about facial anatomy, the implementation of filler injections and the management of complications is essential for the practitioner. The patient should be clarified about potential and even rare risks of these procedures.
format Online
Article
Text
id pubmed-8858863
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88588632022-03-02 Ophthalmic artery occlusion after glabellar hyaluronic acid filler injection Davidova, Petra Müller, Michael Wenner, Yaroslava König, Clara Kenikstul, Ninel Kohnen, Thomas Am J Ophthalmol Case Rep Case Report PURPOSE: Filler injections for aesthetic purposes are very popular, but can have far-reaching and irreversible consequences. This report describes the course of a patient with devastating complications after glabellar hyaluronic acid injection, their pathomechanism, management and outcome. OBSERVATIONS: A healthy, 43-year-old woman underwent her first hyaluronic acid injection in the glabella and went blind on her left eye immediately thereafter. Massaging of the injection area and observation were performed, before she presented with swelling of the left forehead and upper lid, ptosis, complete ophthalmoplegia and blindness in our hospital. Immediate massaging of the globe and systemic therapy including acetylsalicylic acid, tinzaparin sodium and cortisone was initiated and hyaluronidase injections in the injection area were performed. In the further course, the patient developed necrotic and hemorrhagic skin and mucosal lesions, lagophthalmos, anterior and posterior segment ischemia and globe hypotonia with consecutive globe deformation. In the follow-up of 2.5 months, lid swelling, lagophthalmos and ptosis resolved and keratopathy improved but blindness, skin lesions and strabismus with reduced eye motility were still present and madarosis and early enophthalmos were detected. CONCLUSIONS AND IMPORTANCE: The outcome of ophthalmic artery occlusion after hyaluronic acid filler injection is poor. Sufficient knowledge about facial anatomy, the implementation of filler injections and the management of complications is essential for the practitioner. The patient should be clarified about potential and even rare risks of these procedures. Elsevier 2022-02-11 /pmc/articles/PMC8858863/ /pubmed/35243152 http://dx.doi.org/10.1016/j.ajoc.2022.101407 Text en © 2022 The Authors. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Davidova, Petra
Müller, Michael
Wenner, Yaroslava
König, Clara
Kenikstul, Ninel
Kohnen, Thomas
Ophthalmic artery occlusion after glabellar hyaluronic acid filler injection
title Ophthalmic artery occlusion after glabellar hyaluronic acid filler injection
title_full Ophthalmic artery occlusion after glabellar hyaluronic acid filler injection
title_fullStr Ophthalmic artery occlusion after glabellar hyaluronic acid filler injection
title_full_unstemmed Ophthalmic artery occlusion after glabellar hyaluronic acid filler injection
title_short Ophthalmic artery occlusion after glabellar hyaluronic acid filler injection
title_sort ophthalmic artery occlusion after glabellar hyaluronic acid filler injection
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858863/
https://www.ncbi.nlm.nih.gov/pubmed/35243152
http://dx.doi.org/10.1016/j.ajoc.2022.101407
work_keys_str_mv AT davidovapetra ophthalmicarteryocclusionafterglabellarhyaluronicacidfillerinjection
AT mullermichael ophthalmicarteryocclusionafterglabellarhyaluronicacidfillerinjection
AT wenneryaroslava ophthalmicarteryocclusionafterglabellarhyaluronicacidfillerinjection
AT konigclara ophthalmicarteryocclusionafterglabellarhyaluronicacidfillerinjection
AT kenikstulninel ophthalmicarteryocclusionafterglabellarhyaluronicacidfillerinjection
AT kohnenthomas ophthalmicarteryocclusionafterglabellarhyaluronicacidfillerinjection